echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Ascletis Anti-COVID-19 Oral Dual Prodrug ASC10 Business Progress

    Ascletis Anti-COVID-19 Oral Dual Prodrug ASC10 Business Progress

    • Last Update: 2022-05-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    HANGZHOU AND SHAOXING, March 15, 2022 /PRNewswire/ -- Ascletis Pharma Co.


    Based on a series of optimization measures, the production cost of ASC10 has dropped significantly, which is critical to the availability of anti-COVID-19 drugs


    1.


    2.


    3.


    The latest experimental data show that ASC10-A has potent cellular-level resistance to the Omicron variant (EC50 = 0.


    ASC10 is an oral dual prodrug of the antiviral nucleoside analog ASC10-A, which has a potent inhibitory effect on novel coronavirus polymerase (RdRp)


    So far, Ascletis has filed a number of patent applications for ASC10 and its uses worldwide


    About Song Li

    Ascletis is an innovative R&D-driven biotechnology company listed on the Hong Kong Stock Exchange (1672.


    1.


    2.


    3.


    4.


    Source: Ascletis Pharma Co.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.